Profound Medical Corp. (PROF)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS

2400 SKYMARK AVENUE, UNIT 6 MISSISSAUGA, ONTARIO, CANADA L4W 5K5

Profound is a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue. Profound is commercializing TULSA-PRO®, a technology that combines real-time MRI, robotically-driven transurethral ultrasound and closed-loop temperature feedback control. TULSA-PRO® is designed to provide customizable and predictable radiation-free ablation of a surgeon-defined prostate volume while actively protecting the urethra and rectum to help preserve the patient's natural functional abilities. TULSA-PRO® has the potential to be a flexible technology in customizable prostate ablation, including intermediate stage cancer, localized radio-recurrent cancer, retention and hematuria palliation in locally advanced prostate cancer, and the transition zone in large volume benign prostatic hyperplasia (BPH). TULSA-PRO® is CE marked, Health Canada approved, and 510(k) cleared by the U.S. Food and Drug Administration ('FDA'). Profound is also commercializing Sonalleve®, an innovative therapeutic platform that is CE marked for the treatment of uterine fibroids and palliative pain treatment of bone metastases. Sonalleve® has also been approved by the China National Medical Products Administration for the non-invasive treatment of uterine fibroids and has FDA approval under a Humanitarian Device Exemption for the treatment of osteoid osteoma. The Company is in the early stages of exploring additional potential treatment markets for Sonalleve® where the technology has been shown to have clinical application, such as non-invasive ablation of abdominal cancers and hyperthermia for cancer therapy.

Data as of 2021-08-02 09:09:54 -0400
Market Cap297.552 Million Shares Outstanding20.38 Million Avg 30-day Volume51.313 Thousand
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-41.13 Enterprise Value
Total Cash Current Debt Gross Profit
BETA1.03417 52-week High/Low28.97 / 13.7 Next Earnings Date2021-08-04 Price to Cash FLow (P/CF) -44.2593
Data provided by IEX Cloud
View SEC Filings from PROF instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 1 1 0.0% 1 (0.06%) 1 (0.06%) 0.0%
Funds Holding: 52 55 -5.45% 22 (1.29%) 24 (1.39%) -8.33%
13F shares: 8.672 Million 8.261 Million 4.98% 5.452 Million 4.784 Million 13.97%
% Ownership 42.7412 42.0914 1.54% 26.8722 24.3751 10.24%
New Positions: 5 14 -64.29% 1 5 -80.0%
Increased Positions 18 18 0.0% 10 9 11.11%
Closed Positions 8 4 100.0% 3 4 -25.0%
Reduced Positions 18 13 38.46% 7 5 40.0%
Total Calls 136.151 Thousand 121.401 Thousand 12.15% 57.6 Thousand 25.3 Thousand 127.67%
Total Puts 88.203 Thousand 95.703 Thousand -7.84% 13.2 Thousand 20.7 Thousand -36.23%
PUT/CALL Ratio 0.65 0.79 -17.72% 0.23 0.82 -71.95%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

Funds Holding PROF (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding PROF BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
PROFOUND MEDICAL CORP PROF 2021-08-05 22:15:04 UTC -4.1579 4.2379 150000
PROFOUND MEDICAL CORP PROF 2021-08-05 21:45:03 UTC -4.0808 4.1608 150000
PROFOUND MEDICAL CORP PROF 2021-08-05 21:15:03 UTC -4.0808 4.1608 150000
PROFOUND MEDICAL CORP PROF 2021-08-05 20:45:03 UTC -4.0808 4.1608 150000
PROFOUND MEDICAL CORP PROF 2021-08-05 20:15:04 UTC -4.0808 4.1608 150000
PROFOUND MEDICAL CORP PROF 2021-08-05 19:45:04 UTC -4.0808 4.1608 150000
PROFOUND MEDICAL CORP PROF 2021-08-05 19:15:03 UTC -4.0808 4.1608 150000
PROFOUND MEDICAL CORP PROF 2021-08-05 18:45:03 UTC -4.0808 4.1608 150000
PROFOUND MEDICAL CORP PROF 2021-08-05 18:15:03 UTC -4.0808 4.1608 150000
PROFOUND MEDICAL CORP PROF 2021-08-05 17:45:03 UTC -4.0808 4.1608 150000
PROFOUND MEDICAL CORP PROF 2021-08-05 17:15:03 UTC -4.0808 4.1608 150000
PROFOUND MEDICAL CORP PROF 2021-08-05 16:45:02 UTC -4.1591 4.2391 150000
PROFOUND MEDICAL CORP PROF 2021-08-05 16:15:03 UTC -4.1591 4.2391 150000
PROFOUND MEDICAL CORP PROF 2021-08-05 15:45:03 UTC -4.1591 4.2391 150000
PROFOUND MEDICAL CORP PROF 2021-08-05 15:15:02 UTC -4.1591 4.2391 150000
PROFOUND MEDICAL CORP PROF 2021-08-05 14:45:02 UTC -4.1664 4.2464 150000
PROFOUND MEDICAL CORP PROF 2021-08-05 14:15:04 UTC -4.1664 4.2464 150000
PROFOUND MEDICAL CORP PROF 2021-08-05 13:45:04 UTC -4.1664 4.2464 150000
PROFOUND MEDICAL CORP PROF 2021-08-05 13:15:03 UTC -4.1664 4.2464 150000
PROFOUND MEDICAL CORP PROF 2021-08-05 12:45:03 UTC -4.1664 4.2464 150000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments